Amitriptyline is a tricyclic antidepressant that was synthesised in 1960 and introduced as early as 1961 in the USA, but is still regularly used. It has also been frequently used as an active comparator in trials on newer antidepressants and can therefore be called a 'benchmark' antidepressant. However, its efficacy and safety compared to placebo in the treatment of major depression has not been assessed in a systematic review and meta-analysis.
CITATION STYLE
Leucht, C., Huhn, M., & Leucht, S. (2012). Amitriptyline versus placebo for major depressive disorder. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd009138.pub2
Mendeley helps you to discover research relevant for your work.